Randomized, Controlled Trial With Hybrid Fractional Laser
Randomized, Controlled Trial With Hybrid Fractional Laser for Vulvovaginal Atrophy in Breast Cancer Survivors and Menopausal Females
Sponsor: Sciton
Listed as NCT03647189, this NA trial focuses on Vaginal Atrophy, Sexual Dysfunction, Vaginal Dryness, Dyspareunia and remains completed. Sponsored by Sciton, it has been updated 12 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Mar 2021 — Sep 2021 [monthly]
Recruiting NA
-
Jan 2021 — Mar 2021 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
-
Sep 2020 — Nov 2020 [monthly]
Recruiting NA
-
Feb 2020 — Sep 2020 [monthly]
Recruiting NA
-
Jan 2020 — Feb 2020 [monthly]
Recruiting NA
-
May 2019 — Jan 2020 [monthly]
Recruiting NA
-
Oct 2018 — May 2019 [monthly]
Recruiting NA
-
Sep 2018 — Oct 2018 [monthly]
Recruiting NA
First recorded
Aug 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sciton
For direct contact, visit the study record on ClinicalTrials.gov .